Ultragenyx Pharmaceutical Inc. ($RARE)
Filing Information
| Accession Number | 0001193125-26-089287 |
|---|---|
| Form Type | 4 |
| Filing Date | Mar 3, 2026 |
| Document | View SEC Filing |
Transactions
2
Total Shares
21,166
Total Value
$228,661.20
P&L
+inf% (+$227,863.02)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
EVP, Chief Quality Operations Officer | Common Stock | โ | Mar 1, 2026 | Grant/Award | 11,137 | $0.00 | $0.00 | 119,565 | Direct | โ | View Details | |
EVP, Chief Quality Operations Officer | Common Stock | โ | Mar 2, 2026 | Sale | 10,029 | $22.80 | $228,661.20 | 110,026 | Direct | โ | View Details |